litlas
Log inCreate account

Éric Bruckert

Active 1988–2025

Also published as
Eric Bruckert
145
Papers
38,644
Citations
89
h-index
144
i10-index

Citations

Citations per year for Éric Bruckert1985: 4 citations1987: 2 citations1989: 2 citations1990: 2 citations1991: 12 citations1992: 13 citations1993: 10 citations1994: 13 citations1995: 9 citations1996: 30 citations1997: 15 citations1998: 10 citations1999: 12 citations2000: 20 citations2001: 54 citations2002: 84 citations2003: 149 citations2004: 180 citations2005: 178 citations2006: 197 citations2007: 191 citations2008: 179 citations2009: 194 citations2010: 235 citations2011: 207 citations2012: 189 citations2013: 219 citations2014: 243 citations2015: 302 citations2016: 394 citations2017: 357 citations2018: 363 citations2019: 1,209 citations2020: 1,373 citations2021: 1,455 citations2022: 1,179 citations2023: 990 citations2024: 1,500 citations2025: 672 citations2026: 70 citations1986: no citations, so this year is not shown1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,340 citing papers, 20.4% of this breakdownChina: 1,112 citing papers, 6.8% of this breakdownUnited Kingdom: 1,082 citing papers, 6.6% of this breakdownItaly: 1,005 citing papers, 6.1% of this breakdownFrance: 769 citing papers, 4.7% of this breakdownCanada: 717 citing papers, 4.4% of this breakdownGermany: 683 citing papers, 4.2% of this breakdownAustralia: 552 citing papers, 3.4% of this breakdownNetherlands: 548 citing papers, 3.3% of this breakdownSpain: 486 citing papers, 3% of this breakdownJapan: 363 citing papers, 2.2% of this breakdownDenmark: 330 citing papers, 2% of this breakdown
0%20.4%Other 32.9%

Institutions

Fields

  • Medicine79.6%
  • Biochemistry, Genetics and Molecular Biology12.2%
  • Immunology and Microbiology2%
  • Nursing1.4%
  • Neuroscience1.3%
  • Agricultural and Biological Sciences0.6%
  • Other2.9%

Topics

  • Lipoproteins and Cardiovascular Health12.3%
  • Diabetes, Cardiovascular Risks, and Lipoproteins7.6%
  • Liver Disease Diagnosis and Treatment6.1%
  • Adipokines, Inflammation, and Metabolic Diseases3%
  • Lipid metabolism and disorders2.9%
  • Cholesterol and Lipid Metabolism2.8%
  • Other65.3%

Coauthors

All papers

Open in search
  1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Authors: Brian A. Ference, Henry N. Ginsberg, Ian Graham, Kausik K. Ray, Chris J. Packard, Éric Bruckert, Robert A. Hegele, Ronald M. Krauss, Frederick J. Raal, Heribert Schunkert, Gerald F. Watts, Jan Borén, Sergio Fazio, Jay D. Horton, L. Masana, Stephen J. Nicholls, Børge G. Nordestgaard, Bart van de Sluis, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Ulf Landmesser, Ulrich Laufs, Olov Wiklund, Jane K. Stock, M. John Chapman, Alberico L. Catapano - European Heart Journal 2017 cited by 3,840

  2. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Authors: Jan Borén, M. John Chapman, Ronald M. Krauss, Chris J. Packard, Jacob Fog Bentzon, Christoph J. Binder, Mat J.A.P. Daemen, Linda L. Demer, Robert A. Hegele, Stephen J. Nicholls, Børge G. Nordestgaard, Gerald F. Watts, Éric Bruckert, Sergio Fazio, Brian A. Ference, Ian Graham, Jay D. Horton, Ulf Landmesser, Ulrich Laufs, L. Masana, Gerard Pasterkamp, Frederick J. Raal, Kausik K. Ray, Heribert Schunkert, Marja‐Riitta Taskinen, Bart van de Sluis, Olov Wiklund, Lâle Tokgözoğlu, Alberico L. Catapano, Henry N. Ginsberg - European Heart Journal 2020 cited by 1,527

  3. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

    Authors: Marianne Abifadel, Mathilde Varret, Jean‐Pierre Rabès, Delphine Allard, Khadija Ouguerram, Martine Devillers, Corinne Cruaud, Suzanne Benjannet, L. Alexandra Wickham, D. Erlich, Aurélie Derré, Ludovic Villéger, Michel Farnier, Isabel Beucler, Éric Bruckert, Jean Chambaz, B. Chanu, Jean‐Michel Lecerf, Gérald Luc, Philippe Moulin, Jean Weissenbach, Annik Prat, Michel Krempf, Claudine Junien, Nabil G. Seidah, Cathérine Boileau - Nature Genetics 2003 cited by 3,011

  4. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

    Authors: Joseph L. Witztum, Daniel Gaudet, Steven D. Freedman, Veronica Alexander, Andrés Digenio, Karren Williams, Qingqing Yang, Steven G. Hughes, Richard S. Geary, Marcello Arca, Erik S.G. Stroes, Jean Bergeron, Handrean Soran, Fernando Civeira, Linda Hemphill, Sotirios Tsimikas, Dirk Blom, Louis O’Dea, Éric Bruckert - New England Journal of Medicine 2019 cited by 669

  5. Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

    Authors: Vlad Ratziu, Frédéric Charlotte, A. Heurtier, Sophie Gombert, Philippe Giral, Éric Bruckert, André Grimaldi, Frédérique Capron, Thierry Poynard - Gastroenterology 2005 cited by 2,078

  6. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    Authors: Marina Cuchel, Frederick J. Raal, Robert A. Hegele, Khalid Al‐Rasadi, Marcello Arca, Maurizio Averna, Éric Bruckert, Tomáš Freiberger, Daniel Gaudet, Mariko Harada‐Shiba, Lisa C. Hudgins, Meral Kayıkçıoğlu, L. Masana, Klaus G. Parhofer, Jeanine E. Roeters van Lennep, Raúl D. Santos, Erik S.G. Stroes, Gerald F. Watts, Albert Wiegman, Jane K. Stock, Lâle Tokgözoğlu, Alberico L. Catapano, Kausik K. Ray - European Heart Journal 2023 cited by 331

  7. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Authors: Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini, Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Éric Bruckert, Guy De Backer, Ronald M. Krauss, Ulrich Laufs, Raúl D. Santos, Robert A. Hegele, G. Kees Hovingh, Lawrence A. Leiter, François Mach, Winfried März, Connie B. Newman, Olov Wiklund, Terry A. Jacobson, Alberico L. Catapano, M. John Chapman, Henry N. Ginsberg, European Atherosclerosis Society Consensus Panel, Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini, Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Eric Bruckert, Ronald M. Krauss, Ulrich Laufs, Raul D. Santos, Winfried März, Connie B. Newman, M. John Chapman, Henry N. Ginsberg, M. John Chapman, Henry N. Ginsberg, Guy De Backer, Alberico L. Catapano, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Lawrence A. Leiter, François Mach, Olov Wiklund - European Heart Journal 2015 cited by 1,420

  8. Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: Ioanna Gouni‐Berthold, Veronica J. Alexander, Qingqing Yang, Eunju Hurh, Elisabeth Steinhagen‐Thiessen, Patrick M. Moriarty, Stephen G. Hughes, Daniel Gaudet, Robert A. Hegele, Louis O’Dea, Erik S.G. Stroes, Sotirios Tsimikas, Joseph L. Witztum, Abhay Kumar Agarwal, Christie M. Ballantyne, Seth J. Baum, Jean Bergeron, Éric Bruckert, Richard K. Burdick, Manuel Castro-Cabezas, Mark Cervi, Clinton N. Corder, Robert Dufour, Cecil Murray Farrington, Gordon Francis, Lawrence Galitz, Steven Hamstead, Linda Hemphill, Cynthia Huffman, Basil Issa, Ulrich Julius, John P. Kane, Michel Krempf, Steven W. Martin, James J. Powell, Richard Shultzaberger, Craig Thompson, Letitia Thompson-Hargrave, Peter P. Tóth, Traci Turner, René Valéro, Bruno Vergès, Frank L.J. Visseren, Pankaj Vyas, Alberto R. Yataco - The Lancet Diabetes & Endocrinology 2021 cited by 226

  9. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke

    Authors: Pierre Amarenco, Kim Js, Julien Labreuche, Hugo Charles, Jérémy Abtan, Yannick Béjot, Lucie Cabrejo, Cha Jk, Grégory Ducrocq, Maurice Giroud, Céline Guidoux, Cristina Hobeanu, Kim Yj, Bertrand Lapergue, Philippa C. Lavallée, Lee Bc, Lee Kb, Didier Leys, Mahagne Mh, Elena Meseguer, Norbert Nighoghossian, Fernando Pico, Yves Samson, Igor Sibon, Philippe Gabríel Steg, Sung Sm, Pierre‐Jean Touboul, Emmanuel Touzé, Olivier Varenne, Éric Vicaut, Nessima Yelles, Éric Bruckert - New England Journal of Medicine 2019 cited by 565

  10. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

    Authors: Børge G. Nordestgaard, Anne Langsted, Samia Mora, Genovefa Kolovou, H Baum, Éric Bruckert, Gerald F. Watts, Grażyna Sypniewska, Olov Wiklund, Jan Borén, M. John Chapman, Christa M. Cobbaert, Olivier Descamps, Arnold von Eckardstein, Pia R. Kamstrup, Kari Pulkki, Florian Kronenberg, Alan T. Remaley, Nader Rifai, Emilio Ros, Michel R. Langlois - European Heart Journal 2016 cited by 835

  11. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    Authors: Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons, Kanika Dharmayat, Tomáš Freiberger, G. Kees Hovingh, Pedro Mata, Frederick J. Raal, Raúl D. Santos, Handrean Soran, Gerald F. Watts, Marianne Abifadel, Carlos A. Aguilar-Salinas, Khalid F. AlHabib, Mutaz Al-Khnifsawi, Wael Almahmeed, Fahad Alnouri, Rodrigo Alonso, Khalid Al‐Rasadi, Ahmad Al‐Sarraf, Nasreen Al-Sayed, Francisco Araújo, Tester F. Ashavaid, Maciej Banach, Sophie Béliard, Marianne Benn, Christoph J. Binder, Martin P. Bogsrud, Mafalda Bourbon, Krzysztof Chlebus, Pablo Corral, Kairat Davletov, Olivier Descamps, Ronen Durst, М. В. Ежов, Dan Gaiță, Jacques Genest, Urh Grošelj, Mariko Harada‐Shiba, Kirsten B. Holven, Meral Kayıkçıoğlu, Weerapan Khovidhunkit, Katarina Lalić, Gustavs Latkovskis, Ulrich Laufs, Evangelos Liberopoulos, Marcos M. Lima-Martínez, Jie Lin, Vincent Maher, Adéle Marais, Winfried März, Erkin М Мirrakhimov, André R. Miserez, Olena Mitchenko, Hapizah Nawawi, Børge G. Nordestgaard, Andrie G. Panayiotou, György Paragh, Žaneta Petrulionienė, Belma Pojskić, Arman Postadzhiyan, Katarı́na Rašlová, Ashraf Reda, Željko Reiner, Fouzia Sadiq, Wilson E. Sadoh, Heribert Schunkert, Aleksandr B. Shek, Mario Stoll, Erik S.G. Stroes, Ta‐Chen Su, Tavintharan Subramaniam, Andrey V. Susekov, Myra Tilney, Brian Tomlinson, Thanh Huong Truong, Alexandros D. Tselepis, Anne Tybjærg‐Hansen, Alejandra Cárdenas, Margus Viigimaa, Luya Wang, Shizuya Yamashita, John J.P. Kastelein, Éric Bruckert, Branislav Vohnout, Laura Schreier, Jing Pang, Christoph Ebenbichler, Hans Dieplinger, Reinhold Innerhofer, Yvonne Winhofer-Stöckl, Susanne Greber‐Platzer, Konstantin A. Krychtiuk, Walter S. Speidl, Hermann Toplak, Kurt Widhalm, Thomas M. Stulnig, Kurt Huber, Florian Höllerl, Gersina Rega‐Kaun and 624 more - The Lancet 2021 cited by 305

  12. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

    Authors: Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh, Antonio J. Vallejo‐Vaz, Kausik K. Ray, Handrean Soran, Tomáš Freiberger, Stefano Bertolini, Mariko Harada‐Shiba, Dirk Blom, Frederick J. Raal, Marina Cuchel, Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh, Antonio J. Vallejo‐Vaz, Kausik K. Ray, Handrean Soran, Tomáš Freiberger, Stefano Bertolini, Mariko Harada‐Shiba, Jing Pang, Gerald F. Watts, Susanne Greber‐Platzer, Martin Mäser, Thomas M. Stulnig, Christoph Ebenbichler, Khalid Bin Thani, David Cassiman, Olivier Descamps, Daisy Rymen, Peter Witters, Raúl D. Santos, Liam R. Brunham, Gordon A. Francis, Jacques Genest, Robert A. Hegele, Brooke A. Kennedy, Isabelle L. Ruel, Mark Sherman, Long Jiang, Luya Wang, Željko Reiner, V. Bláha, R Češka, Jana Dvořáková, Lubomir Dlouhy, Pavel Hořák, Vladimír Soška, Lukáš Tichý, Robin Urbánek, H Vaverková, Michal Vrablı́k, Stanislav Zemek, Lukáš Zlatohlávek, Sameh Emil, Tarek Naguib, Ashraf Reda, Sophie Béliard, Éric Bruckert, Antonio Gallo, Moses Elisaf, Genovefa Kolovou, Hofit Cohen, Ronen Durst, Eldad J. Dann, Avishay Elis, Osama Hussein, Eran Leitersdorf, Daniel Schurr, Nitika Setia, Ishwar C. Verma, Mohammed Alareedh, Mutaz Al-Khnifsawi, Ali Fawzi Abdalsahib Al-Zamili, Sabah H. Rhadi, Foaad Shaghee, Marcello Arca, Maurizio Averna, Andrea Bartuli, Marco Bucci, Paola Sabrina Buonuomo, Paolo Calabrò, S. Calandra, Manuela Casula, Alberico L. Catapano, Angelo B. Cefalù, Arrigo F.G. Cicero, Sergio D’Addato, Laura D’Erasmo, Alessia Di Costanzo, Tommaso Fasano, Marta Gazzotti, Antonina Giammanco, Gabriella Iannuzzo, Anastasia Ibba, Emanuele Alberto Negri, Andrea Pasta, Chiara Pavanello, Livia Pisciotta and 73 more - The Lancet 2022 cited by 207

  13. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    Authors: Albert Wiegman, Samuel S. Gidding, Gerald F. Watts, M. John Chapman, Henry N. Ginsberg, Marina Cuchel, Leiv Ose, Maurizio Averna, Cathérine Boileau, Jan Borén, Éric Bruckert, Alberico L. Catapano, Joep C. Defesche, Olivier Descamps, Robert A. Hegele, G. Kees Hovingh, Steve E. Humphries, Petri T. Kovanen, Jan Albert Kuivenhoven, L. Masana, Børge G. Nordestgaard, Päivi Pajukanta, Klaus G. Parhofer, Frederick J. Raal, Kausik K. Ray, Raúl D. Santos, Anton F. H. Stalenhoef, Elisabeth Steinhagen- Thiessen, Erik S.G. Stroes, Marja‐Riitta Taskinen, Anne Tybjærg‐Hansen, Olov Wiklund - European Heart Journal 2015 cited by 870

  14. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

    Authors: François Mach, Kausik K. Ray, Olov Wiklund, Alberto Corsini, Alberico L. Catapano, Éric Bruckert, Guy De Backer, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Ronald M. Krauss, Ulrich Laufs, Lawrence A. Leiter, Winfried März, Børge G. Nordestgaard, Frederick J. Raal, Michael Roden, Raúl D. Santos, Evan A. Stein, Erik S.G. Stroes, Paul D Thompson, Lâle Tokgözoğlu, Georgirene D. Vladutiu, Bariş Gencer, Jane K. Stock, Henry N. Ginsberg, M. John Chapman, European Atherosclerosis Society Consensus Panel - European Heart Journal 2018 cited by 381

  15. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance

    Authors: Steven E. Nissen, Erik S.G. Stroes, Ricardo E. Dent‐Acosta, Robert S. Rosenson, Sam J. Lehman, Naveed Sattar, David Preiss, Éric Bruckert, R Češka, Norman E. Lepor, Christie M. Ballantyne, Ioanna Gouni-Berthold, Mary Elliott, Danielle M. Brennan, Scott M. Wasserman, Ransi Somaratne, Rob Scott, Evan A. Stein, for the GAUSS-3 Investigators - JAMA 2016 cited by 511

  16. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    Authors: M. Cuchel, Éric Bruckert, H. N. Ginsberg, F. J. Raal, R. D. Santos, Robert A. Hegele, Jan Albert Kuivenhoven, Børge G. Nordestgaard, Olivier Descamps, E. Steinhagen-Thiessen, Anne Tybjærg‐Hansen, Gerald F. Watts, Maurizio Averna, Cathérine Boileau, Jan Borén, Alberico L. Catapano, Joep C. Defesche, G. Kees Hovingh, Steve E. Humphries, Petri T. Kovanen, L. Masana, P. Pajukanta, Klaus G. Parhofer, Kausik K. Ray, Anton F. H. Stalenhoef, Erik S.G. Stroes, Marja‐Riitta Taskinen, Albert Wiegman, Olov Wiklund, M. John Chapman, for the European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia, M. Cuchel, Éric Bruckert, M. John Chapman, O. S. Descamps, H. N. Ginsberg, Robert A. Hegele, Jan Albert Kuivenhoven, B. G. Nordestgaard, F. J. Raal, R. D. Santos, E. Steinhagen-Thiessen, Anne Tybjærg‐Hansen, Gerald F. Watts, M. John Chapman, Henry N. Ginsberg, Maurizio Averna, Cathérine Boileau, J. Boren, Alberico L. Catapano, Joep C. Defesche, G. K. Hovingh, Steve E. Humphries, Petri T. Kovanen, L. Masana, P. Pajukanta, Klaus G. Parhofer, Kausik K. Ray, Anton F. H. Stalenhoef, Erik S.G. Stroes, Marja‐Riitta Taskinen, Albert Wiegman, Olov Wiklund - European Heart Journal 2014 cited by 1,053

  17. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

    Authors: Patrick M. Moriarty, Paul D. Thompson, Christopher P. Cannon, John R. Guyton, Jean Bergeron, Franklin J. Zieve, Éric Bruckert, Terry A. Jacobson, Stephen L. Kopecky, Marie T. Baccara‐Dinet, Yunling Du, Robert Pordy, Daniel A. Gipe - Journal of clinical lipidology 2015 cited by 467

  18. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”

    Authors: Philippe Moulin, Robert Dufour, Maurizio Averna, Marcello Arca, Angelo B. Cefalù, Davide Noto, Laura D’Erasmo, Alessia Di Costanzo, Christophe Marçais, Alvarez-Sala Jl, Maciej Banach, Jan Borén, Robert Cramb, Ioanna Gouni‐Berthold, Elizabeth Hughes, Colin Johnson, Xavier Pintó, Željko Reiner, Jeanine E. Roeters van Lennep, Handrean Soran, Claudia Stefanutti, Erik Stroes, Eric Bruckert - Atherosclerosis 2018 cited by 242

  19. Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study

    Authors: Éric Bruckert, Gilles Hayem, S. Dejager, Caroline Yau, Bernard Bégaud - Cardiovascular Drugs and Therapy 2005 cited by 1,240

  20. Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

    Authors: Vlad Ratziu, Philippe Giral, Sophie Jacqueminet, Frédéric Charlotte, Agnès Hartemann–Heurtier, Lawrence Serfaty, Philippe Podevin, Jean‐Marc Lacorte, Carole Bernhardt, Éric Bruckert, André Grimaldi, Thierry Poynard - Gastroenterology 2008 cited by 622

  21. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

    Authors: Børge G. Nordestgaard, Michel R. Langlois, Anne Langsted, M. John Chapman, Kristin M. Aakre, H Baum, Jan Borén, Éric Bruckert, Alberico L. Catapano, Christa M. Cobbaert, Paul Collinson, Olivier Descamps, Christopher J. Duff, Arnold von Eckardstein, Angelika Hammerer‐Lercher, Pia R. Kamstrup, Genovefa Kolovou, Florian Kronenberg, Samia Mora, Kari Pulkki, Alan T. Remaley, Nader Rifai, Emilio Ros, Sanja Stanković, Ana Stavljenić-Rukavina, Grażyna Sypniewska, Gerald F. Watts, Olov Wiklund, Päivi Laitinen - Atherosclerosis 2019 cited by 238

  22. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

    Authors: Robert A. Hegele, Henry N. Ginsberg, M. John Chapman, Børge G. Nordestgaard, Jan Albert Kuivenhoven, Maurizio Averna, Jan Borén, Éric Bruckert, Alberico L. Catapano, Olivier Descamps, G. Kees Hovingh, Steve E. Humphries, Petri T. Kovanen, L. Masana, Päivi Pajukanta, Klaus G. Parhofer, Frederick J. Raal, Kausik K. Ray, Raúl D. Santos, Anton F. H. Stalenhoef, Erik S.G. Stroes, Marja‐Riitta Taskinen, Anne Tybjærg‐Hansen, Gerald F. Watts, Olov Wiklund - The Lancet Diabetes & Endocrinology 2013 cited by 634

  23. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

    Authors: Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Tóth, Ioanna Gouni‐Berthold, John Mancini, David Marais, Patrick M. Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragoş Vinereanu, Arrigo F.G. Cicero, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Maciej Banach, Ioanna Gouni‐Berthold, Sonu Bhaskar, Agata Bielecka‐Dąbrowa, Bojko Bjelaković, Éric Bruckert, Ibadete Bytyçi, Alberto Cafferata, Richard Češka, Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djurić, Ronen Durst, М. В. Ежов, Zlatko Fras, Dan Gaiță, Ioanna Gouni‐Berthold, Adrían V. Hernández, Steven R. Jones, Jacek Jerzy Jozwiak, N. Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martínez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin М Мirrakhimov, André R. Miserez, Olena Mitchenko, N. P. Mitкоvsкаyа, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Žaneta Petrulionienė, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenković, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Maria-Corina Șerban, Abdullah Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Tóth, Margus Viigimaa, Pedro Valdivielso, Dragoş Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablı́k, Nathan D. Wong, Hung‐I Yeh, Jiang Zhisheng, Andreas Zirlik - Pharmacological Research 2023 cited by 68

  24. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

    Authors: Michel R. Langlois, M. John Chapman, Christa M. Cobbaert, Samia Mora, Alan T. Remaley, Emilio Ros, Gerald F. Watts, Jan Borén, H Baum, Éric Bruckert, Alberico L. Catapano, Olivier Descamps, Arnold von Eckardstein, Pia R. Kamstrup, Genovefa Kolovou, Florian Kronenberg, Anne Langsted, Kari Pulkki, Nader Rifai, Grażyna Sypniewska, Olov Wiklund, Børge G. Nordestgaard - Clinical Chemistry 2018 cited by 258